Drawing for INIZAN

USPTO serial 85264167

INIZAN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ALVAREZ, COURTNEY
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INIZAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cheryl L. Foytlin

CHERYL L FOYTLIN JOHNSON JOHNSON1 JOHNSON AND JOHNSON PLZNEW BRUNSWICK, NJ 08933 0002UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases; Human pharmaceuticals for use as hemostatic agentsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 13, 2012MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Mar 13, 2012ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Mar 13, 2012OP.TOPPOSITION TERMINATED NO. 999999—
Mar 13, 2012OP.DOPPOSITION DISMISSED NO. 999999—
Jan 24, 2012OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 22, 2011ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 26, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 6, 2011NPUBNOTICE OF PUBLICATION—
Jun 9, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2011DOCKASSIGNED TO EXAMINER—
Mar 16, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 14, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance